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Abstract
The role of Enterococcus spp. as a cause of catheter-related bloodstream infections (CR-BSI) is almost unexplored. We assessed the
incidence and clinical characteristics of enterococcal CR-BSI (ECR-BSI) over an 8-year period in our hospital. We performed a retro-
spective study (January 2003 to December 2010) in a large teaching institution. We recorded the incidence, and the microbiological
and clinical data from patients with ECR-BSI. The incidence per 10 000 admissions for enterococcal BSI and ECR-BSI was 25 and
1.7, respectively. ECR-BSI was the fourth leading cause of CR-BSI in our institution (6%). A total of 75 episodes of ECR-BSI were
detected in 73 patients (6% of all enterococcal BSI). The incidence of ECR-BSI increased by 17% annually (95% CI 19.0–21.0%) during
the study period. Nineteen percent of ECR-BSI episodes were polymicrobial. Overall mortality was 33%. ECR-BSI is an emerging and
increasingly common entity with a high mortality. This ﬁnding should be taken into account when selecting empirical treatment for
presumptive CR-BSI.
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Introduction
Catheter-related bloodstream infections (CR-BSI) are one of
the most important types of nosocomial infections, with high
rates of morbidity and mortality and high healthcare costs
[1,2]. CR-BSI are mainly caused by gram-positive bacteria,
particularly coagulase-negative Staphylococcus and Staphylococ-
cus aureus.
Enterococci are a common cause of bloodstream infec-
tions in the USA [3] and in Europe [4]. However, the litera-
ture contains little information on Enterococcus spp. as a
cause of CR-BSI [5–10].
The aim of our study was to assess how the incidence
and clinical characteristics of enterococcal CR-BSI (ECR-BSI)
evolved over an 8-year period in a large teaching institution.
Material and Methods
Setting
We performed a retrospective study from January 2003 to
December 2010 in a tertiary teaching hospital serving a ref-
erence population that ranged from 704 030 to 806 769
inhabitants during the study period. Patients with ECR-BSI
were identiﬁed using the microbiology laboratory database.
Data collected
Patient data were collected from hospital medical records.
Clinical data included demographics, McCabe and Jackson
prognosis of underlying diseases, and the Charlson comor-
bidity index [11,12]. For adult intensive care unit (ICU)
patients, we calculated the Acute Physiological Assessment
and Chronic Health Evaluation (APACHE) II score at the
time of catheter withdrawal. We also recorded microbiologi-
cal data from catheter and blood cultures. Other data
included neutropenia (neutrophil count £500/lL) within the
7 days before catheter withdrawal, transplantation, and
immunosuppressive treatment during the previous month.
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Surgical procedures on admission and antibiotic treatment
and outcome were also recorded.
Deﬁnitions
The deﬁnitions for CR-BSI are those detailed in the Clinical
Practice Guidelines for the Diagnosis and Management of
Intravascular Catheter-Related Infections [13]. Diagnosis of
proven CR-BSI was based on growth of the same Enterocco-
cus spp. (at species level) from at least one percutaneous
blood culture and from a culture of the catheter tip within a
period of 7 days of the positive blood culture.
All enterococcal isolates from blood from the same
patient within 1 week are considered as a single episode.
Polymicrobial CR-BSI was deﬁned as the presence of colo-
nization of the catheter tip and bacteraemia caused by two
or more signiﬁcant microorganisms.
Laboratory procedures
Our institution recommends extraction of three blood sam-
ples (10 mL each in adults) for evaluation of all episodes of
suspected bacteraemia. Blood cultures were processed
according to routine methods using a semiautomatic culture
detector (Bactec 9240; Becton Dickinson Microbiology Sys-
tems, Maryland, DE, USA). Catheter tips were cultured using
the Maki roll-plate technique [14,15] considering signiﬁcant
growth as ‡15 CFU/plate. Microorganisms were identiﬁed
and antibiotic susceptibility was tested using the automated
MicroScan system (DADE Behring, Sacramento, CA, USA).
Statistical analysis
The incidence of enterococcal BSI, ECR-BSI and CR-BSI was
calculated as episodes per 10 000 admissions (the number of
episodes detected during the study period divided by the
number of admissions during the same period). We used SPSS
12.0 (SPSS Inc., Chicago, IL, USA) for the statistical analysis.
Ethics
The study was approved by the Ethics Committee of Hospi-
tal General Universitario Gregorio Maran˜o´n.
Results
During the study period, Enterococcus spp. was the fourth
leading cause of CR-BSI (after coagulase-negative Staphylococ-
cus, S. aureus, and Candida spp.) and represented 6% of all
episodes of CR-BSI (75/1208 episodes). Of the 333 catheters
colonized with Enterococcus spp., 75 were ECR-BSI (23%); of
1193 episodes of enterococcal bacteraemia, 6% (75/1193)
were catheter-related.
The overall incidence of proven CR-BSI and ECR-BSI was
25 and 1.7 episodes per 10 000 admissions, respectively. We
recorded a 17% annual increase in incidence (95% CI 16.1–
17.9%), ranging from 0.9 episodes per 10 000 admissions in
2003 to 1.8 episodes per 10 000 admissions in 2010 (Poisson
regression, p <0.001).
The yearly change of ECR-BSI is compared with the yearly
changes of other gram-positive CR-BSI in Fig. 1.
The incidence of ECR-BSI due to Enterococcus faecalis
increased by 20.0% annually (95% CI 19.0–21.0%) during the
study period (p <0.001) whereas the incidence of ECR-BSI
due to Enterococcus faecium remained stable.
The yearly changes of ECR-BSI due to E. faecalis is com-
pared with the yearly changes of ECR-BSI due to E. faecium
in Fig. 2.
Most episodes of ECR-BSI were caused by E. faecalis
(85%); the remaining episodes were caused by E. faecium
(15%). In 19% of cases, ECR-BSI was polymicrobial. The asso-
ciated pathogens were gram-negative bacilli (43.75%), coagu-
lase-negative Staphylococcus (43.75%) and S. aureus (12.5%).
The same species of enterococci were isolated concurrently
from another site in 15% (11/73) of patients.
All E. faecalis isolates were susceptible to ampicillin,
whereas only 10% of E. faecium isolates were susceptible to
ampicillin. Thirty-three percent of Enterococcus spp. isolates
were resistant to gentamicin. There were no vancomycin-
resistant isolates.
The characteristics of the catheters from patients with
ECR-BSI are detailed in Table 1. Most catheters (76%) were
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FIG. 1. Yearly incidence of enterococcal and Staphylococcus aureus
catheter-related bloodstream infections per 10 000 admissions. ECR-
BSI, enterococcal catheter-related bloodstream infection; S. aureus
CR-BSI, Staphylococcus aureus catheter-related bloodstream infection.
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central venous catheters. The most frequent site of insertion
was the subclavian vein (34.6%), followed by the jugular vein
(26.6%), femoral vein (20%), upper extremities (14.6%), and
other (4%). Median indwelling time was 15 days (interquartile
range 12–25). In most cases (70%), the reason for catheter
withdrawal was suspicion of bloodstream infection.
We identiﬁed 75 episodes of ECR-BSI in 73 patients.
Demographic and clinical data are summarized in Table 2.
Slightly more than half of all ECR-BSI episodes (53%)
occurred in units other than adult ICUs. Cardiovascular dis-
ease was the most common underlying condition, followed
by malignancy and gastrointestinal disease. Sixty-one patients
underwent at least one surgical procedure during admission
(44% abdominal, 38% cardiac and 18% other).
Complications occurred in 11% of the episodes. Endocar-
ditis was diagnosed in 4% of cases of ECR-BSI. The remaining
complications were recurrent bacteraemia in three patients
(4%), mediastinitis in one patient (1.3%), and abdominal
abscess in one patient (1.3%). Overall mortality was 36%.
Discussion
Enterococcus spp. are the fourth most common cause of CR-
BSI in our institution. ECR-BSI accounts for 6% of all epi-
sodes of CR-BSI and 6% of all enterococcal BSI and occurs
in patients with severe underlying conditions. It is polymicro-
bial in 19% of episodes and is associated with signiﬁcant rates
of morbidity and mortality.
Enterococcal-BSI has classically been related to intra-
abdominal, urinary tract and soft-tissue infections [16].
Enterococcal endocarditis has been reported to occur in 8%
of cases of enterococcal bacteraemia [17]. Enterococci are
TABLE 1. Catheter characteristics of enterococcal catheter-
related bloodstream infection
Variable Overall (n = 75)
Catheter daysa 15 (12–25)
Insertion siteb
Subclavian vein 26 (34.6)
Jugular vein 20 (26.6)
Femoral vein 15 (20)
Upper extremities 11 (14.6)
Other 3 (4)
Type of catheterb
Central venous catheter 57 (76)
Peripherally inserted central catheter 10 (13)
Swan–Ganz 3 (4)
Arterial 2 (3)
Port-A-Cath 2 (3)
Hickman 1 (1)
Reason for catheter withdrawalb
Suspicion of bloodstream infection 53 (71)
Unknown 15 (20)
End of use 4 (5)
Obstruction 2 (3)
Suspicion of local infection 1 (1)
aValues expressed as median (interquartile range).
bValues expressed as no. (%) of patients.
TABLE 2. Clinical features of patients with enterococcal
catheter-related bloodstream infection
Variable Overall (n = 75)
Agea 60 (11–71)
Maleb 42 (56)
Hospitalization unitb
Intensive-care unit 35 (47)
Medical 12 (16)
Surgical 9 (12)
Paediatric 19 (25)
Underlying diseaseb
Cardiovascular 26 (35)
Malignancy 15 (20)
Gastrointestinal 12 (16)
Other 22 (29)
McCabe and Jackson severity of underlying disease scoreb
Rapidly fatal 2 (3)
Ultimately fatal 4 (5)
Non-fatal 69 (92)
Charlson comorbidity scorea 2 (0–3)
Previous neutropeniab 2 (3)
Surgical procedure during admissionb 61 (81)
Recent immunosuppressive therapyb 11 (15)
HIV infectionb 2 (3)
Transplantationb 4 (5)
Antimicrobials received in the previous monthb 70 (93)
Need for ICU admissionb 64 (85)
APACHE II scorea (n = 35) 13 (11–15)
Length of hospital stay, daysa 29 (14–53)
Length of ICU stay, daysa 24 (11–46)
Complicationsb
Endocarditis 3 (4)
Recurrent bacteraemia 3 (4)
Mediastinitis 1 (1.3)
Abdominal abscess 1 (1.3)
Global mortality at dischargeb 27 (36)
ICU, intensive care unit; HIV, human immunodeﬁciency virus; ECR-BSI, entero-
coccal catheter-related bloodstream infection.
aValues expressed as median (interquartile range).
bValues expressed as no. (%) of patients.
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FIG. 2. Yearly incidence of Enterococcus faecalis and Enterococcus fae-
cium catheter-related bloodstream infections per 10 000 admissions.
ECR-BSI, enterococcal catheter-related bloodstream infection.
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the fourth commonest cause of nosocomial infections and
the third commonest cause of bacteraemia, accounting for
10.2% of BSI [18]. In Europe, enterococcal bacteraemia
accounts for 7.2% of all BSIs [18].
Our data show that enterococcal CR-BSI is an emerging
condition whose incidence has been increasing in recent
years. Previous studies have reported catheter-related infec-
tion as a source in 2–13% of enterococcal BSI [5,16]. In our
experience, at least 6% of all episodes of enterococcal
bacteraemia originate from a catheter; therefore, this site
should be taken into consideration when searching for an
origin in patients with enterococcal bacteraemia.
A survey of CR-BSI that collected data from 21 European
countries revealed an overall incidence of 0.6 episodes of
ECR-BSI per 10 000 admissions [19]. In our institution, the
incidence of ECR-BSI was signiﬁcantly higher, accounting for
1.7 episodes per 10 000 admissions. This ﬁgure doubled over
an 8-year period, to the detriment of other gram-positive
microorganisms such as S. aureus.
The incidence of CR-BSI outside the ICU has received lit-
tle attention in the medical literature [20,21]. However, in
our study, most ECR-BSI episodes occurred in units other
than adult ICUs.
The vast majority of the patients in our series had under-
lying clinical conditions with high morbidity and mortality
rates, making it difﬁcult to attribute mortality, especially in
the case of ECR-BSI. Enterococcal BSI mortality has been
reported to range from 13% to 68% [22,23]. We identiﬁed
three endocarditis episodes secondary to ECR-BSI, all due to
E. faecalis, and three patients presented recurrent bactera-
emia, all with high-level gentamicin resistance. Enterococcal
BSI that exhibit high-level gentamicin resistance have been
associated with more severe underlying disease and higher
mortality than non-high-level gentamicin resistance infections
[24]. In our study, a high proportion (28%) of the patients
who died had ECR-BSI with high-level gentamicin resistance.
We did not ﬁnd any correlation between outcome and resis-
tance to ampicillin. The absence of vancomycin-resistant en-
terococcal isolates prevented us from analysing a potential
association between vancomycin-resistant enterococci and
outcome.
Nosocomial enterococcal bacteraemia is often polymicro-
bial [8,16,17]. A high proportion (19%) of the ECR-BSI epi-
sodes we detected were polymicrobial (two or more
microorganisms in both the catheter and the blood culture).
Patterson et al. [8] found that the most common Enterococ-
cus spp. polymicrobial infection was CR-BSI.
Nine of the 75 patients with ECR-BSI had one or more
different microorganisms present in blood cultures that were
not present in the catheter-tip culture. We think that these
cases could have an intra-abdominal origin and that the cath-
eter could have become infected as a result of metastatic
seeding.
Our study was limited by its retrospective design and the
fact that it did not include a control group; therefore, we
were unable to analyse attributable mortality and compare
the clinical outcome of ECR-BSI with that of CR-BSI caused
by other microorganisms. Moreover, the absence of vanco-
mycin-resistant enterococci limited the applicability of our
ﬁndings to other scenarios. However, ours is the largest ser-
ies collected to date from a single centre.
In conclusion, Enterococcus spp. is an emerging cause of
CR-BSI, which should be considered when selecting empirical
treatments of presumptive CR-BSI. The episodes of ECR-BSI
frequently had polymicrobial blood cultures, suggesting a
potential intra-abdominal origin with secondary catheter
involvement. The high mortality rate of patients with ECR-
BSI means that every effort should be made to establish the
optimal therapeutic approach.
Moreover, the high proportion of ECR-BSI occurring in
units other than adult ICUs highlights the need to expand
CR-BSI surveillance programmes to include non-ICU areas.
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